10
Sep 2025

Kidney Cancer Treatment in Mohali & Chandigarh: Breakthroughs Patients Should Know in 2025


A New Era of Kidney Cancer Care in Mohali & Chandigarh

The year 2025 marks a turning point in kidney cancer treatment. Patients in Chandigarh and Mohali now have access to therapies that were once considered futuristic. With the rise of robotic surgery, advanced drug therapies, and personalized cancer vaccines, the future of urology cancer surgery looks brighter than ever.

Under the guidance of specialists like Dr Dharmender Aggarwal, patients no longer need to travel outside Punjab for cutting-edge treatment.

Why Kidney Cancer Has Been Difficult to Treat

Unlike some cancers, kidney cancer—especially clear cell renal cell carcinoma (ccRCC)—does not always respond well to chemotherapy. Late-stage diagnoses make matters worse. But thanks to urology robotic surgery and newly approved systemic therapies, outcomes are rapidly improving for patients in this region.

Robotic Surgery: The Game-Changer in Kidney Cancer

One of the most significant advances is the rise of robotic surgery in Mohali and Chandigarh. Unlike traditional open surgery, robotic-assisted procedures offer:

  • Smaller incisions and faster recovery

  • Minimal blood loss

  • Higher precision for tumor removal

  • Better preservation of kidney function

For patients undergoing urology cancer surgery, robotic technology ensures both safety and improved long-term outcomes.

Smart Drugs That Target Cancer

Targeted therapy has transformed the way oncologists treat kidney cancer. Instead of damaging healthy cells, these drugs block pathways that fuel cancer growth.

  • Belzutifan (Welireg): Blocks HIF-2α in the VHL pathway and has shown remarkable success in shrinking tumors.

  • Drug combinations: Researchers are now combining targeted medicines with immunotherapy for even greater results.

For patients seeking Kidney Cancer Treatment in Chandigarh or Mohali, targeted therapy provides a highly personalized approach with fewer side effects.

Immunotherapy: Teaching the Immune System to Fight Back

Immunotherapy has already proven to be one of the most powerful treatments for kidney cancer patients.

  • Checkpoint inhibitors (like Nivolumab and Pembrolizumab) allow the immune system to recognize and destroy cancer cells.

  • Combination regimens have doubled survival rates for some patients with advanced disease.

  • Newer therapies are being tested in trials, with the aim of making immunotherapy even more effective.

For those undergoing urology cancer surgery in Mohali, immunotherapy often works as an excellent follow-up treatment to reduce recurrence risks.

Personalized Cancer Vaccines: Tailored to Each Patient

One of the biggest scientific leaps in 2025 is the creation of personalized kidney cancer vaccines.

Instead of one-size-fits-all, these vaccines are designed from a patient’s own tumor. They train the immune system to prevent cancer from coming back after surgery. In early studies, patients treated with these vaccines remained cancer-free for nearly three years.

This breakthrough offers new hope for patients undergoing Kidney Cancer Treatment in Mohali and Chandigarh who want precision-driven care.

CAR-T Therapy: A Future Hope for Kidney Cancer Patients

CAR-T therapy—where a patient’s immune cells are reprogrammed to fight cancer—has already changed the future of blood cancer. Now, it’s being tested for kidney tumors.

Trials are underway using CAR-T to target tumor-specific proteins like CA9 and PSMA, potentially making kidney cancer treatment even more powerful.

Smarter Radiation: When Surgery Isn’t an Option

Not every patient is a candidate for surgery. That’s where modern radiation comes in:

  • SABR (Stereotactic Ablative Body Radiotherapy): Highly focused radiation with minimal side effects.

  • ART (Adaptive Radiation Therapy): Uses live imaging to adapt treatment in real time.

For kidney cancer patients in Chandigarh and Mohali, these techniques provide good alternatives when surgery isn’t possible.

Can Patients Stop Treatment After a Few Years?

Excitingly, new research shows that some patients responding well to treatment can safely pause therapy after two years. This means fewer side effects, reduced costs, and a much better quality of life, all without affecting survival.

Why Local Patients Benefit from Global Breakthroughs

With cutting-edge Kidney Cancer Treatment in Chandigarh and Mohali, patients don’t need to travel to metro cities anymore. From robotic surgery to advanced immunotherapy, everything is available locally under the expertise of Dr Dharmender Aggarwal, a renowned uro oncologist in Mohali specializing in urology robotic surgery and precision-based cancer care. 

FAQs

Is robotic surgery better than traditional kidney cancer surgery?
Yes. Robotic surgery offers more precision, faster recovery, and better kidney preservation compared to open surgery.

What are the newest drug therapies for kidney cancer?
Targeted medicines like Belzutifan and immunotherapy combinations are currently the most promising drug treatments in 2025.

Are personalized cancer vaccines available in India?
They are still in early clinical trials but are expected to be available in advanced cancer centers, including in Punjab in the near future.

Who is the best uro oncologist for kidney cancer in Mohali?
Dr Dharmender Aggarwal is a leading uro oncologist offering advanced urology cancer surgery and robotic surgery for kidney cancer patients in Mohali and Chandigarh.

Hope for Kidney Cancer Patients in 2025

The journey of Kidney Cancer Treatment is no longer limited to traditional surgery or chemotherapy. With the rise of robotic surgery, targeted drugs, immunotherapy, and cancer vaccines, the outlook for patients has never been brighter.

👉 If you or your loved one is seeking Kidney Cancer Treatment in Mohali or Chandigarh, schedule a consultation with Dr Dharmender Aggarwal today for world-class care, advanced surgical options, and personalized treatment strategies.

📞 Book your appointment now and take a confident step toward recovery.